Has Emily Cha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,040 in general payments to Emily Cha, MD across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emily Cha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emily Cha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emily Cha, MD

Orthopaedic Surgery · Brandywine, MDNPI 1215215678

Payments from drug & device makers

$13,040in general payments, 2019–2025

Across 69 payments — averaging $188.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Crossroads Orthopedics, LLC$7K
Arthrex$5K
Ferring Pharmaceuticals Inc.$233
Stryker$196
Smith+Nephew$188
Zimmer Biomet$76
plus $112 from 6 others

What the payments were for

Travel & lodging$1,84814%
Food & beverage$1,2369%
Education$9,95576%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Crossroads Orthopedics, LLC	10	$6,864
Arthrex	31	$5,370
Ferring Pharmaceuticals Inc.	10	$233
Stryker	5	$196
Smith+Nephew	4	$188
Zimmer Biomet	2	$76
Johnson & Johnson	2	$26
Pacira Pharmaceuticals Incorporated	1	$26
Medtronic	1	$19
Orthofix Medical, Inc.	1	$16
Kowa Pharmaceuticals America, Inc.	1	$13
Vericel Corporation	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Regeneten$117

How this compares

$13,040 in reported general payments places this provider in the 70th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland →

Medicare billing

Part B allowed, 2024

$92,540

Medicare patients

252

Services billed

1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	22	$728
Diclofenac Sodium	39	$435
Methylprednisolone	14	$100

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Brandywine

Mark MyersonBaltimore$10.5M
David DaluryTowson$8.1M
Anand MurthiBaltimore$5.4M
Timothy CoddTowson$3.7M
Khaled KebaishBaltimore$3.5M
Hamid HassanzadehBethesda$2M
Michael AinLutherville$1.6M
Paul SponsellerBaltimore$1.5M
Shawn StandardBaltimore$1.4M
Ronald DelanoisBaltimore$1.2M

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →